| BEP | PRESS-RELEASE | bullish | 7/10 | Brookfield Renewable reported record Q1 2026 FFO of $375M ($0.55/unit, +15% YoY per unit), well ahead of prior-year resu | May 1, 2026 |
| RYTM | PRESS-RELEASE | bullish | 7/10 | Rhythm Pharmaceuticals received European Commission approval for IMCIVREE (setmelanotide) to treat acquired hypothalamic | May 1, 2026 |
| WNC | PRESS-RELEASE | mixed | 6/10 | Wabash National reported a weak Q1 2026 with revenue down 20.4% YoY to $303M and GAAP EPS of -$1.11, missing consensus. | May 1, 2026 |
| AIRS | PRESS-RELEASE | neutral | 1/10 | Airsculpt Technologies, Inc. announced it will report its fiscal Q1 2026 results on May 8, 2026. | May 1, 2026 |
| AMG | PRESS-RELEASE | bullish | 6/10 | AMG reported Q1 2026 Economic EPS of $8.23, beating consensus of $8.07 by 2%, while revenue of $544.9M slightly missed t | May 1, 2026 |
| LYB | PRESS-RELEASE | mixed | 6/10 | LyondellBasell reported Q1 2026 GAAP EPS of $0.38 (vs consensus $0.28, beat) but GAAP net income of $125M was down 29% Y | May 1, 2026 |
| NVT | PRESS-RELEASE | neutral | 3/10 | nVent released Q1 2026 earnings via press release; financial details were not directly provided in the filing document. | May 1, 2026 |
| ELLO | PRESS-RELEASE | neutral | 3/10 | Ellomay Capital filed its 2025 annual report (20-F), disclosing adjustments to previously published unaudited results: a | May 1, 2026 |
| HBM | PRESS-RELEASE | mixed | 6/10 | Hudbay Minerals reported Q1 2026 record revenue of $757.3M and record adjusted EBITDA of $421.9M, but GAAP EPS of $0.48 | May 1, 2026 |
| BTSG | PRESS-RELEASE | bullish | 8/10 | BrightSpring Health Services reported Q1 2026 revenue of $3,614M (beat consensus of $3,390M by 6.6%) and GAAP diluted EP | May 1, 2026 |
| LYB | PRESS-RELEASE | neutral | 4/10 | LyondellBasell completed the sale of select European olefins and polyolefins assets to AEQUITA, a key step in its Europe | May 1, 2026 |
| MGA | PRESS-RELEASE | bullish | 7/10 | Magna reported Q1 2026 adjusted EPS of $1.38, a 77% YoY increase and a 37% beat vs. consensus of $1.01, driven by operat | May 1, 2026 |
| MUX | PRESS-RELEASE | neutral | 4/10 | McEwen Inc. completed its acquisition of Golden Lake Exploration via a statutory plan of arrangement, issuing 0.003876 M | Apr 30, 2026 |
| SENS | PRESS-RELEASE | bearish | 7/10 | Senseonics priced an $80M underwritten public offering of 8M shares at $5.00/share plus 8M pre-funded warrants at $4.999 | Apr 30, 2026 |
| RNTX | PRESS-RELEASE | bearish | 8/10 | Rein Therapeutics priced a $50M underwritten public offering of 50M shares at $1.00/share, with an underwriter option fo | Apr 30, 2026 |
| TGB | PRESS-RELEASE | neutral | 2/10 | Taseko Mines announced the release date for its Q1 2026 financial results, scheduled for May 6, 2026, after market close | Apr 30, 2026 |
| HELP | PRESS-RELEASE | neutral | 3/10 | Helus Pharma announced a collaboration with TARA Mind to support recruitment for its Phase 3 HLP003 program in major dep | Apr 30, 2026 |
| GTE | PRESS-RELEASE | neutral | 1/10 | Gran Tierra Energy Inc. announced it will report its Q1 2026 results on May 7, 2026. | Apr 30, 2026 |
| COAG | PRESS-RELEASE | neutral | 5/10 | Hemab Therapeutics priced its IPO at $18.00 per share, offering 16.75M shares for gross proceeds of ~$301.5M, with an un | Apr 30, 2026 |
| NVX | PRESS-RELEASE | neutral | 4/10 | Novonix completed the sale of its Battery Technology Solutions (BTS) business in Nova Scotia to former CEO Dr. Chris Bur | Apr 30, 2026 |
| TAC | PRESS-RELEASE | neutral | 2/10 | TransAlta held its Annual and Special Meeting of Shareholders on April 30, 2026, where all nine director nominees were e | Apr 30, 2026 |
| INCR | PRESS-RELEASE | mixed | 6/10 | InterCure reported FY2025 revenue of NIS 270M (+13% YoY), a net loss of NIS 37M (improved from NIS 73M loss in 2024), an | Apr 30, 2026 |
| REI | PRESS-RELEASE | neutral | 1/10 | Ring Energy, Inc. announced it will report its Q1 2026 results. | Apr 30, 2026 |
| SYNX | PRESS-RELEASE | bullish | 7/10 | Silynxcom reported FY2025 revenue of $5.8M with a gross profit of $2.1M, and highlighted a $7.3M backlog year-to-date th | Apr 30, 2026 |
| YDES | PRESS-RELEASE | bearish | 7/10 | YD Bio reported FY2025 net revenue of $597K (+17% YoY) but net loss widened to $8.3M from $1.4M, driven by a $3.2M warra | Apr 30, 2026 |
| FBLG | PRESS-RELEASE | neutral | 5/10 | FibroBiologics reported Q1 2026 EPS of -$0.60, a 55.7% beat vs consensus of -$1.35, but net loss was flat YoY at $5.0M. | Apr 30, 2026 |
| XE | PRESS-RELEASE | neutral | 4/10 | X-energy (XE) announced a collaboration with LG&E and KU (PPL subsidiaries) to explore deploying its Xe-100 SMR in Kentu | Apr 30, 2026 |
| MEOH | PRESS-RELEASE | bearish | 7/10 | Methanex reported Q1 2026 EPS of $0.30, a 28.6% miss versus the $0.42 consensus, with no revenue figure provided in the | Apr 30, 2026 |
| ASTL | PRESS-RELEASE | neutral | 1/10 | Algoma Steel Inc announced it will report its Q1 2026 results on May 12, 2026. | Apr 30, 2026 |
| MSEX | PRESS-RELEASE | neutral | 5/10 | Middlesex Water reported Q1 2026 diluted EPS of $0.57, slightly below the $0.59 consensus, and revenue of $48.7M, below | Apr 30, 2026 |